Article

ForbesForbes on 2023-08-29 22:59

How This Manufacturer Turned Big Pharma’s Commercialization Model Upside Down

When Pfizer acquired Biohaven for $11.6 billion, many big Pharma executives began to question their own beliefs and commercial tactics.

Related news